UPL Limited

UPL Limited in its US$4.2 billion acquisition of Arysta LifeScience


UPL Limited


US$4.2 billion


Mergers and Acquisitions

Date Closed

January 2019



Lead Office



On February 1, 2019, UPL Limited announced the completion of its acquisition of Arysta LifeScience Inc. from Platform Specialty Products, a chemical production corporation listed on the NYSE, for US$4.2 billion.

UPL Limited is a leader in global food systems and with the acquisition of Arysta, becomes one of the top 5 agricultural solutions companies worldwide. With revenue of approximately US$5 billion, it has a footprint in 76 countries and sales in 130+ countries.

Arysta, based in Tokyo, is a global provider of innovative crop protection solutions, including BioSolutions and Seed Treatment.  

Osler, Hoskin & Harcourt LLP acted as Canadian counsel to UPL Limited with a team led Chris Murray (Corporate) that consisted of Joyce Bernasek (Financial Services), Patrick Welsh (Litigation), and Joshua Disenhouse (Real Estate).